XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Other Expense (Income)
 9 Months Ended
Sep. 30, 2024
Other Income and Expenses [Abstract]  
Other Expense (Income) Other Expense (Income)
Other expense (income) consists of:
Three Months Ended
September 30,		Nine Months Ended
September 30,
($ in millions)2024202320242023
Foreign exchange transaction losses$4.1 $1.8 $7.3 $3.0 
Contingent consideration1.2 0.7 3.2 1.5 
Asset impairments1.0 3.5 1.9 6.9 
Restructuring and related charges(2.5)— (2.5)(0.8)
Loss on disposal of plant— — — 11.6 
Other items0.6 (0.4)0.9 0.3 
Total other expense (income)$4.4 $5.6 $10.8 $22.5 
Contingent Consideration

Contingent consideration represents changes in the fair value of the SmartDose® contingent consideration. Please refer to Note 10, Fair Value Measurements, for additional details.

Restructuring and Related Charges

In December 2022, the Company approved a restructuring plan to adjust our operating cost base to better respond to the macroeconomic factors influencing our business. These changes were implemented over a period of approximately twenty-four months from the date of approval. The plan is expected to have annualized savings in the range of $17 million to $19 million. As of September 30, 2024, the Company does not expect additional expenses or payments associated with our 2022 restructuring plan. The following table presents activity related to our restructuring obligations related to our 2022 restructuring plan:
($ in millions)Severance
and benefits		Other chargesTotal
Balance, December 31, 2023$3.0 $— $3.0 
(Credits) Charges(2.5)— (2.5)
Cash payments(0.5)— (0.5)
Balance, September 30, 2024$— $— $— 

Loss on Disposal of Plant

During the nine months ended September 30, 2023, the Company recorded expense of $11.6 million, within other expense (income), as a result of the sale of one of the Company’s manufacturing facilities within the Proprietary Products segment during the second quarter of 2023.